Skip to main content
Caplight Logo









PolarisQB

PolarisQB

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://polarisqb.com/

Last Round

Grant

Aug 27, 2024

Total Funding Raised

$2.1M

Company Overview

PolarisQB is a biotechnology company that has developed a Quantum-Aided Drug Design (QuADD) software-as-a-service platform to accelerate the discovery of new drugs.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Quantum Computing, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

drug discoveryquantum computingdrug discovery AImolecular screeningquantum drug discoveryAI drug discoverylead optimizationin silico drug designADMET predictioncomputational chemistrySaaS platformpredictive modelingbiotech softwarepharma R&Dquantum algorithms

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PolarisQB Comparables

Compare PolarisQB with similar companies based on industry and business-model similarity.

PolarisQB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QSimulate
88%
Kuano
85%
PharmCADD Co., Ltd.
85%

PolarisQB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 27, 2024
GrantOct 18, 2023
StrategicFeb 3, 2022
SeedAug 10, 2021

Key People

Founding team and executive leadership

Bill Shipman

CTO and co-founder

Founding Team

Shahar Keinan

CEO And Co-founder

Founding Team

PolarisQB Investors

Notable investors and investment history

PolarisQB investors
InvestorRounds
Defense Advanced Research Projects AgencyGrant
Infinity MedicalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2026

    New study shows quantum-inspired Hamiltonian feature extraction improves AI-based ADMET prediction.

  • Apr 14, 2026

    Attended Quantum World Day 2026 on April 14, 2026.

PolarisQB Filings

Explore SEC and related filing metadata, where available.

PolarisQB filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PolarisQB's valuation, stock price, and market status.

Is PolarisQB a public or private company?

PolarisQB is a private company.

What is the current stock price of PolarisQB?

PolarisQB is a private company with no public stock price. No recent secondary market data is available.

How much is PolarisQB worth (valuation)?

Valuation information for PolarisQB is not publicly available.

Can I buy PolarisQB stock?

PolarisQB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PolarisQB's last funding round?

PolarisQB's most recent funding round was Grant on August 27, 2024.

Who are the main investors in PolarisQB?

Key investors in PolarisQB include Defense Advanced Research Projects Agency.

Will PolarisQB IPO soon?

No public IPO plans have been announced for PolarisQB.

How can I track PolarisQB secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PolarisQB's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range8
Year Founded2020
Last FundingAug 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?